- Home
- SONN vs SCNX Comparison
SONN vs SCNX Comparison
Compare SONN & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SONN
- SCNX
- Stock Information
- Founded
- SONN N/A
- SCNX 2010
- Country
- SONN United States
- SCNX United States
- Employees
- SONN N/A
- SCNX N/A
- Industry
- SONN Biotechnology: Pharmaceutical Preparations
- SCNX Other Pharmaceuticals
- Sector
- SONN Health Care
- SCNX Health Care
- Exchange
- SONN Nasdaq
- SCNX Nasdaq
- Market Cap
- SONN 32.4M
- SCNX 31.5M
- IPO Year
- SONN N/A
- SCNX 2020
- Fundamental
- Price
- SONN $3.20
- SCNX $0.82
- Analyst Decision
- SONN Strong Buy
- SCNX
- Analyst Count
- SONN 1
- SCNX 0
- Target Price
- SONN $20.00
- SCNX N/A
- AVG Volume (30 Days)
- SONN 503.8K
- SCNX 63.1M
- Earning Date
- SONN 12-16-2025
- SCNX 11-12-2025
- Dividend Yield
- SONN N/A
- SCNX N/A
- EPS Growth
- SONN N/A
- SCNX N/A
- EPS
- SONN N/A
- SCNX N/A
- Revenue
- SONN $1,000,000.00
- SCNX $128,202.00
- Revenue This Year
- SONN $5,376.22
- SCNX N/A
- Revenue Next Year
- SONN N/A
- SCNX N/A
- P/E Ratio
- SONN N/A
- SCNX N/A
- Revenue Growth
- SONN 1689.52
- SCNX N/A
- 52 Week Low
- SONN $1.08
- SCNX $0.46
- 52 Week High
- SONN $19.30
- SCNX $8.81
- Technical
- Relative Strength Index (RSI)
- SONN 38.92
- SCNX 48.09
- Support Level
- SONN $4.42
- SCNX $0.69
- Resistance Level
- SONN $5.15
- SCNX $1.10
- Average True Range (ATR)
- SONN 0.63
- SCNX 0.34
- MACD
- SONN -0.07
- SCNX -0.02
- Stochastic Oscillator
- SONN 2.93
- SCNX 16.70
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.